On the public citation graph

An Open-Label Study of the Effectiveness and Safety of Fexinidazole for Gambiense Human African Trypanosomiasis, Including an Exploration of Adherence in Outpatients

https://doi.org/10.2139/ssrn.4797648
0 signed · 12 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.actatropica.2004.10.001openalex-extracted
Sleep structure: a new diagnostic tool for stage determination in sleeping sickness
inferredcites →https://doi.org/10.1016/s0140-6736(17)32758-7openalex-extracted
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial
inferredcites →https://doi.org/10.1016/s1473-3099(22)00660-0openalex-extracted
Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial
inferredcites →https://doi.org/10.1016/s2214-109x(21)00208-4openalex-extracted
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
inferredcites →https://doi.org/10.1016/s2214-109x(22)00338-2openalex-extracted
Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2–3 trial
inferredcites →https://doi.org/10.1128/aac.00246-11openalex-extracted
Antitrypanosomal Activity of Fexinidazole, a New Oral Nitroimidazole Drug Candidate for Treatment of Sleeping Sickness
inferredcites →https://doi.org/10.1152/physiol.00006.2004openalex-extracted
Why Trypanosomes Cause Sleeping Sickness
inferredcites →https://doi.org/10.1371/journal.pntd.0000923openalex-extracted
Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness
inferredcites →https://doi.org/10.1371/journal.pntd.0001525openalex-extracted
Actigraphy in Human African Trypanosomiasis as a Tool for Objective Clinical Evaluation and Monitoring: A Pilot Study
inferredcites →https://doi.org/10.1371/journal.pntd.0010047openalex-extracted
The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020
inferredcites →https://doi.org/10.3390/diseases10040069openalex-extracted
Communities’ Perception, Knowledge, and Practices Related to Human African Trypanosomiasis in the Democratic Republic of Congo
inferredcites →https://doi.org/10.4269/ajtmh.20-0340openalex-extracted
The Actigraphy Sleep Score: A New Biomarker for Diagnosis, Disease Staging, and Monitoring in Human African Trypanosomiasis
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.